Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Albemarle Swings to Profit, Lowers Spending Amid Prolonged Lithium Slump August 2, 2025 Quimbaya Gold Announces Termination of LOI with Denarius Metals August 2, 2025 Crypto Market Update: Markets Pull Back After Fed Holds Interest Rates Steady August 2, 2025